Today, the U.S. stock market opened with a mixed performance. Tech stocks showed strong performance, driving the Nasdaq Composite Index to rise by 0.5%, while the S&P 500 Index also edged up by 0.24%. Meanwhile, the Dow Jones Industrial Average remained nearly stable.

However, pharmaceutical industry giants are facing challenges. Danish pharmaceutical company Novo Nordisk's stock price plummeted by 21% after the company lowered its sales growth and profit expectations for 2025. American pharmaceutical giant Merck also did not escape unscathed, with its stock price falling by 5.4%, as the company simultaneously announced a layoff plan.

In contrast, aerospace manufacturing giant Boeing has delivered good news, with its second-quarter performance exceeding market expectations, driving a 1.5% pump in its stock price.

It is worth noting that the Nasdaq Golden Dragon China Index, which represents the performance of Chinese concept stocks, has risen by 0.7%, indicating that investors maintain confidence in Chinese-related stocks.

The differentiation in stock market performance reflects the current complex economic environment. On one hand, the technology sector continues to show strong growth momentum; on the other hand, traditional industries, especially the pharmaceutical industry, are facing the dual challenges of slowing growth and cost pressures. Investors need to closely monitor the specific trends in each industry and formulate investment strategies with caution.